mTOR inhibitors in pediatric kidney transplantation.

mTOR inhibitors in pediatric kidney transplantation.

Item
http://www.wikidata.org/entity/Q38112331
Metabolic consequences of modern immunosuppressive agents in solid organ transplantationRole of mTOR Inhibitors in Kidney DiseaseEfficacy and Safety of an Everolimus- vs. a Mycophenolate Mofetil-Based Regimen in Pediatric Renal Transplant RecipientsSirolimus therapy in a child with partially diazoxide-responsive hyperinsulinaemic hypoglycaemia.Choosing the right dose of tacrolimus.Surveillance biopsies after paediatric kidney transplantation: A review.Role of mTOR inhibitors for the control of viral infection in solid organ transplant recipients.Calcineurin inhibitor- and corticosteroid-free immunosuppression in pediatric heart transplant patients.Everolimus for pediatric patients with acute graft-versus-host disease after hematopoietic stem cell transplantation: A pilot study.Treatment of renal angiomyolipoma in tuberous sclerosis complex (TSC) patients.Sirolimus and tacrolimus coefficient of variation is associated with rejection, donor-specific antibodies, and nonadherence.Regulation of human T cell responses by dNP2-ctCTLA-4 inhibits human skin and microvessel graft rejection
P2860

mTOR inhibitors in pediatric kidney transplantation.

Item
http://www.wikidata.org/entity/Q38112331
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
mTOR inhibitors in pediatric kidney transplantation.
@en
type
label
mTOR inhibitors in pediatric kidney transplantation.
@en
prefLabel
mTOR inhibitors in pediatric kidney transplantation.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P6179
P698
P356
P1433
P1476
mTOR inhibitors in pediatric kidney transplantation.
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P6179
P698